299 related articles for article (PubMed ID: 24481452)
1. The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells.
O'Donnell EF; Koch DC; Bisson WH; Jang HS; Kolluri SK
Cell Death Dis; 2014 Jan; 5(1):e1038. PubMed ID: 24481452
[TBL] [Abstract][Full Text] [Related]
2. Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.
Rowland LK; Campbell PS; Mavingire N; Wooten JV; McLean L; Zylstra D; Thorne G; Daly D; Boyle K; Whang S; Unternaehrer J; Brantley EJ
J Cell Biochem; 2019 Apr; 120(4):6004-6014. PubMed ID: 30450577
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
[TBL] [Abstract][Full Text] [Related]
4. Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERα.
Chen Z; Xia X; Chen H; Huang H; An X; Sun M; Yao Q; Kim K; Zhang H; Chu M; Chen R; Bhutia YD; Ganapathy V; Kou L
Invest New Drugs; 2022 Dec; 40(6):1216-1230. PubMed ID: 36070108
[TBL] [Abstract][Full Text] [Related]
5. Mitophagy Induction and Aryl Hydrocarbon Receptor-Mediated Redox Signaling Contribute to the Suppression of Breast Cancer Cell Growth by Taloxifene
Tran VT; Pham DV; Choi DY; Park PH
Antioxid Redox Signal; 2022 Nov; 37(13-15):1030-1050. PubMed ID: 35286219
[No Abstract] [Full Text] [Related]
6. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.
Safe S; Wormke M; Samudio I
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):295-306. PubMed ID: 14973392
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells.
Jang HS; Pearce M; O'Donnell EF; Nguyen BD; Truong L; Mueller MJ; Bisson WH; Kerkvliet NI; Tanguay RL; Kolluri SK
Biology (Basel); 2017 Dec; 6(4):. PubMed ID: 29194351
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S
Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.
Goode GD; Ballard BR; Manning HC; Freeman ML; Kang Y; Eltom SE
Int J Cancer; 2013 Dec; 133(12):2769-80. PubMed ID: 23733406
[TBL] [Abstract][Full Text] [Related]
11. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
[TBL] [Abstract][Full Text] [Related]
12. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
[TBL] [Abstract][Full Text] [Related]
13. Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression.
Vogel CF; Li W; Wu D; Miller JK; Sweeney C; Lazennec G; Fujisawa Y; Matsumura F
Arch Biochem Biophys; 2011 Aug; 512(1):78-86. PubMed ID: 21640702
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
Bekki K; Vogel H; Li W; Ito T; Sweeney C; Haarmann-Stemmann T; Matsumura F; Vogel CF
Pestic Biochem Physiol; 2015 May; 120():5-13. PubMed ID: 25987214
[TBL] [Abstract][Full Text] [Related]
15. Effect of dioxin and 17β-estradiol on the expression of cytochrome P450 1A1 gene via an estrogen receptor dependent pathway in cellular and xenografted models.
Go RE; Hwang KA; Kim CW; Byun YS; Nam KH; Choi KC
Environ Toxicol; 2017 Oct; 32(10):2225-2233. PubMed ID: 28618207
[TBL] [Abstract][Full Text] [Related]
16. The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
Jin UH; Lee SO; Pfent C; Safe S
BMC Cancer; 2014 Jul; 14():498. PubMed ID: 25011475
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.
DuSell CD; Nelson ER; Wittmann BM; Fretz JA; Kazmin D; Thomas RS; Pike JW; McDonnell DP
Mol Endocrinol; 2010 Jan; 24(1):33-46. PubMed ID: 19901195
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor induced intratumoral aromatase in breast cancer.
Saito R; Miki Y; Hata S; Ishida T; Suzuki T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Feb; 161(3):399-407. PubMed ID: 27900579
[TBL] [Abstract][Full Text] [Related]
19. A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptor.
Fukasawa K; Kagaya S; Maruyama S; Kuroiwa S; Masuda K; Kameyama Y; Satoh Y; Akatsu Y; Tomura A; Nishikawa K; Horie S; Ichikawa Y
Mol Cancer Ther; 2015 Feb; 14(2):343-54. PubMed ID: 25522763
[TBL] [Abstract][Full Text] [Related]
20. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.
Zhang S; Lei P; Liu X; Li X; Walker K; Kotha L; Rowlands C; Safe S
Endocr Relat Cancer; 2009 Sep; 16(3):835-44. PubMed ID: 19447902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]